Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2b Diabetic Kidney Disease Study

ClinicalTrials.gov ID: NCT04170543

Public ClinicalTrials.gov record NCT04170543. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects With Diabetic Kidney Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects with Diabetic Kidney Disease

Study identification

NCT ID
NCT04170543
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
609 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 101 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 18, 2019 (Actual)
Primary completion
May 16, 2023 (Actual)
Completion
May 16, 2023 (Actual)
Last update posted
Jul 10, 2024

2019 – 2023

United States locations

U.S. sites
49
U.S. states
24
U.S. cities
45
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209 —
Research Site Huntsville Alabama 35805 —
Research Site Mesa Arizona 85210 —
Research Site Alhambra California 91801 —
Research Site Glendale California 91204 —
Research Site Granada Hills California 91344 —
Research Site Huntington Park California 90255 —
Research Site Northridge California 91324 —
Research Site Sacramento California 95821 —
Research Site San Diego California 92123 —
Research Site San Dimas California 91773 —
Research Site Vacaville California 95687 —
Research Site Fleming Island Florida 32003 —
Research Site Hialeah Florida 33016 —
Research Site Jacksonville Florida 32204 —
Research Site Miami Florida 33015 —
Research Site Atlanta Georgia 30338 —
Research Site Honolulu Hawaii 96814 —
Research Site Chicago Illinois 60607 —
Research Site Chicago Illinois 60643 —
Research Site Iowa City Iowa 52242 —
Research Site Manhattan Kansas 66502 —
Research Site Topeka Kansas 66606 —
Research Site Wichita Kansas 67214 —
Research Site Flint Michigan 48504 —
Research Site Henderson Nevada 89014 —
Research Site Las Vegas Nevada 89129 —
Research Site Berlin New Jersey 08009 —
Research Site Charlotte North Carolina 28204 —
Research Site Greensboro North Carolina 27408 —
Research Site Greenville North Carolina 27834 —
Research Site Morehead City North Carolina 28557 —
Research Site Maumee Ohio 43537 —
Research Site Oklahoma City Oklahoma 73116 —
Research Site Bethlehem Pennsylvania 18017 —
Research Site East Providence Rhode Island 02915 —
Research Site Columbia South Carolina 29203 —
Research Site Memphis Tennessee 38119 —
Research Site Cypress Texas 77429 —
Research Site Houston Texas 77004 —
Research Site Houston Texas 77079 —
Research Site Katy Texas 77450 —
Research Site San Antonio Texas 78212 —
Research Site San Antonio Texas 78229 —
Research Site San Antonio Texas 78251 —
Research Site St. George Utah 84790 —
Research Site Burke Virginia 22015 —
Research Site Tacoma Washington 98405 —
Research Site Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04170543, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2024 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04170543 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →